Learning Objectives:

1. Discuss the unique features and factors impacting health outcomes in AYAs with cancer

2. Discuss a feasibility study of measuring symptom burden using standardized instruments in AYA patients with hematologic malignancies and integrating palliative care specialists into the treatment team

3. Describe the neurocognitive issues impacting survivors of acute lymphoblastic leukemia (ALL), and discuss the ongoing efforts to describe neurocognitive outcomes in the AYAs with ALL

Session date: 
Monday, December 14, 2020 - 12:00pm to 1:00pm
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Amy Y. Wang, MD, MPH